{
    "code": 0,
    "data": [
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3 & M9 FY26",
            "news_id": "f74804f7-c710-4c6b-9e21-d4d9b31ccfe4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4a06638-c881-49e1-88ce-e7de62e608d4.pdf",
            "news_date": "2026-02-12 18:01:01",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 & M9 FY26",
            "news_id": "c3f2a354-26f9-47ec-9d83-5180d7527cfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=763318ae-b6f3-4301-81b5-28ce5ceebbae.pdf",
            "news_date": "2026-02-12 12:53:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Un-Audited Financial Results for the quarter and nine months ended 31st December 2025",
            "news_id": "0cb16dd4-7435-40ac-b7fb-4ff3e6007ebb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca83733-485b-44f5-a103-7b49060f19ae.pdf",
            "news_date": "2026-02-11 14:44:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning call transcript",
            "news_id": "d1da2805-50e1-437f-a1a0-e3deffb59171",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94dc8ddb-b216-4d23-a04c-7778ad2f7951.pdf",
            "news_date": "2025-11-19 17:56:32",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q2 & H1 FY26",
            "news_id": "8e216b9e-aa75-4cee-9e11-f4e4aa5fd249",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81eb8c14-c7f3-4fb7-9935-485436404cb7.pdf",
            "news_date": "2025-11-13 16:16:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "70ecacdb-7944-4100-be5a-f584dc08b5a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94b73f8b-4b36-46c7-bfcd-bf049d2e084a.pdf",
            "news_date": "2025-11-12 17:10:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-Audited Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "d00f09a9-5eb0-4f08-85ee-8574dd3db309",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddfc9683-6dd5-46bd-a1d7-b156b4175656.pdf",
            "news_date": "2025-11-11 15:37:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call",
            "news_id": "69ab68af-14d0-4572-9f88-f72a13eb9a84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be32446f-df9d-4cd7-9e01-f5c8ae5457e7.pdf",
            "news_date": "2025-08-13 12:37:19",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1 FY2026",
            "news_id": "ffdee26a-1316-40a9-96a9-c2a4098fe06f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cd0111d-6d17-47e8-9f79-7335f9ef2d09.pdf",
            "news_date": "2025-08-08 18:33:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1 FY2026",
            "news_id": "0b42541d-02be-44f5-92fe-8edd22ccaf13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da87a96a-d114-4778-8717-fcddd91e873a.pdf",
            "news_date": "2025-08-07 18:42:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "news_id": "9ada4ff1-5ca5-4718-b52a-5de7c4751383",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a91e1d-ada8-4879-8de9-d48084006cdb.pdf",
            "news_date": "2025-08-07 14:30:09",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call",
            "news_id": "874090ae-bc7a-4c7d-bf0d-2ebe45a62738",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=882c5ebc-c90d-4d32-8c26-c8fb487750d1.pdf",
            "news_date": "2025-05-27 14:47:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 & FY2025",
            "news_id": "e31f0bc8-8ff3-4993-980e-5f65d376d717",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd23a6b9-f149-4961-8a5a-f0cdfcbb646c.pdf",
            "news_date": "2025-05-20 17:39:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 & FY25",
            "news_id": "9ed5f4b6-7a53-41e7-8ca8-b190640ca941",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=278b0efc-94ac-408c-808e-fb328bc7b857.pdf",
            "news_date": "2025-05-19 18:35:20",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Audited Financial Results for the quarter and year ended 31st March 2025",
            "news_id": "d5ae9cb8-2e3e-4435-a37b-584df09e5505",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b62009-dba0-4ff6-80c8-16ee4994867e.pdf",
            "news_date": "2025-05-16 19:06:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings conference call",
            "news_id": "cba8963a-d4be-40d7-b179-3a61ab8573ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a08411-de16-44b4-9bbd-4312ed31c978.pdf",
            "news_date": "2025-02-18 14:41:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY2025",
            "news_id": "4ec66c87-eede-4411-9beb-873dee420bce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6ed3a16-daa9-4976-a8f3-33c3ee2b5a90.pdf",
            "news_date": "2025-02-13 18:19:31",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Un-Audited Financial Results",
            "news_id": "befcb8e5-50b1-4acc-b56c-3f607e389b15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8b40de-da84-473d-b519-ce94cba3a9ad.pdf",
            "news_date": "2025-02-12 18:05:15",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "a31c0a57-20f3-4ebf-aeb0-65e26f9cf4e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e89694a5-3b06-45b8-b3dd-9b51bd52884d.pdf",
            "news_date": "2024-11-26 18:13:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q2&H1-FY2025",
            "news_id": "468c0695-80e4-436e-851f-7773dcbae22c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1461270-00da-47d9-81c3-82e589d39551.pdf",
            "news_date": "2024-11-19 18:18:38",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY2025",
            "news_id": "04dda214-8e3e-4eb6-8175-ef2f30f44d96",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0577f9c7-a51f-4d5c-98fd-b88d31b82e7f.pdf",
            "news_date": "2024-11-18 16:31:53",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2024",
            "news_body": "Financial Results",
            "news_id": "0d576e1c-fba1-4879-86b7-9da86299f940",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12439bfd-cbdf-4361-80e0-c79658f42c1d.pdf",
            "news_date": "2024-11-14 17:00:28",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "f6afe6cb-8989-40ec-877a-a46c7e0bc5a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ca443d-a0fa-4939-98f9-3aede430d721.pdf",
            "news_date": "2024-08-20 15:48:59",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1-FY2025",
            "news_id": "a73d4569-008c-4859-b8f3-0281a86c5693",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d320209f-85d3-41c6-b646-bfa92d72fe82.pdf",
            "news_date": "2024-08-13 14:48:46",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY2025",
            "news_id": "18f4f4eb-c6de-41e7-b0d8-3c4afd6caed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d4e0ee6-7380-4d5f-a8ae-028a6c3e9d7c.pdf",
            "news_date": "2024-08-12 17:32:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2024",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2024",
            "news_id": "d732caea-4f2a-4e6c-9333-dfbb4a9d7c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7da5ca30-8d69-4623-877b-cd2c5935f7c1.pdf",
            "news_date": "2024-08-09 18:37:20",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call,post declaration of audited financial results fpr the quarter and year ended 31st March 2024",
            "news_id": "564c6457-8d5c-4828-a347-982d6d138f57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d97f031c-fe8d-4906-baba-bfb7ebb45612.pdf",
            "news_date": "2024-05-21 17:08:30",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4-2024 & FY2024",
            "news_id": "cf55eb89-3371-4ff8-8ee0-3835ca1cbad6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1ba900d-1182-4e72-89c2-ed990b947791.pdf",
            "news_date": "2024-05-16 17:58:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4-2024 & FY2024",
            "news_id": "e2151405-bad6-4d17-9432-55aa58a0762c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=401a1c0a-205b-4650-8637-4f912e231bb2.pdf",
            "news_date": "2024-05-15 18:34:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 14Th May 2024",
            "news_body": "Outcome of the Board meeting dated 14th May 2024",
            "news_id": "5ee002a6-a06b-42c8-9a8c-741682d9866a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402e2a9a-babd-495d-9d6b-1720b9a9da8f.pdf",
            "news_date": "2024-05-14 16:59:22",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months ended   31st December 2023",
            "news_id": "ebe1d800-dcef-47c6-a45c-a44900d09195",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f277eb-3924-4d04-b777-329db13181c7.pdf",
            "news_date": "2024-02-14 17:45:11",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results  Q3 & 9M FY24",
            "news_id": "b7a69368-80c2-4914-8224-cfcc713a8ebe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168f61ea-257a-4561-8cb8-a952b0619458.pdf",
            "news_date": "2024-02-08 17:47:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 & M9 FY24",
            "news_id": "de75790b-f5b6-4574-9341-da8cc4a14d8d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17f56206-6b62-42e6-91c4-1774a3b34fac.pdf",
            "news_date": "2024-02-07 18:33:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Nine Months Ended 31St December 2023",
            "news_body": "Audited Financial Results for the quarter and nine months ended 31st December 2023",
            "news_id": "27536046-5933-4a53-a38d-75460b210785",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb5dc07-2894-413f-b798-f8b2c4683644.pdf",
            "news_date": "2024-02-06 18:15:02",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call 9th November 2023",
            "news_id": "897e9f20-e617-42e2-9b10-38bb6744ebad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19fb3bea-9b8c-4f80-9ac2-5f737bfff43b.pdf",
            "news_date": "2023-11-16 17:38:47",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results  Q2 & H1 FY24",
            "news_id": "e34ab0ea-d467-46c1-940d-de1a92171925",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=781752c0-1da5-41d6-83a2-d2e6f55035e2.pdf",
            "news_date": "2023-11-09 18:02:40",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 & H1 FY24",
            "news_id": "83f3b4a6-b082-472f-a0cc-350164cb37fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=114aff7c-8d41-43a1-96a9-63e8374ae196.pdf",
            "news_date": "2023-11-09 11:25:43",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter  And Half Year Ended 30Th September 2023",
            "news_body": "Please find attached herewith Audited Financial Results for the quarter and half year ended 30th September 2023",
            "news_id": "14a2ddd8-266d-4373-9e78-d8f79922a231",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d18fc22b-90a7-440f-b0c4-c73624cb7cbe.pdf",
            "news_date": "2023-11-08 16:06:17",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Conference on audited financial results for Q1FY24",
            "news_id": "9df5fef0-64f6-4957-995c-3ac083426d14",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f63768e-65a3-4f15-9db3-3382cb920e7c.pdf",
            "news_date": "2023-08-19 13:59:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1FY24",
            "news_id": "f537c440-9799-497e-990f-2935a33b77a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b499cbb-ae78-4c73-af96-f8bc07688e69.pdf",
            "news_date": "2023-08-16 18:52:41",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1FY24",
            "news_id": "249dd6d9-ae5d-44be-8e61-f17e3af3b5be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f21f477f-8787-4e7b-8567-10970cd664a7.pdf",
            "news_date": "2023-08-14 19:28:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter  Ended 30Th June 2023",
            "news_body": "Audited Financial Results for the quarter ended 30th June 2023",
            "news_id": "0e296954-782f-4784-9884-8906fb5943ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa53b56d-17f0-4743-865b-e5662967637d.pdf",
            "news_date": "2023-08-09 18:05:13",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and year ended 31st March 2023",
            "news_id": "35db3b72-f081-459b-add0-bccce235e0a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68ea1f9-df93-4b28-9254-a2030811aeda.pdf",
            "news_date": "2023-05-17 17:34:43",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results 4Q & FY23",
            "news_id": "297a2827-c283-48ea-aa00-dff1f2c4fed4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0b0c8b-01c5-4fdc-a99f-c4fb7933c3c6.pdf",
            "news_date": "2023-05-10 13:31:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "1b0c0a99-ed88-4d95-a7fb-12ca235e6b27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=664d1893-4c50-469b-b2e4-8ec6c6434d01.pdf",
            "news_date": "2023-05-08 14:09:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting-Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March 2023",
            "news_body": "Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended 31st March 2023",
            "news_id": "9fbf3ccf-0a66-48a9-883d-572117464f80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=419ac7bb-be60-4684-a935-8b0c9f79dff0.pdf",
            "news_date": "2023-04-28 13:54:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q3 & 9M FY23",
            "news_id": "2bcce80a-88da-4493-93b4-5219cd731843",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b77ac1fa-969a-402d-9d7c-c34c9d693447.pdf",
            "news_date": "2023-02-09 16:47:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "b96ac0ac-f87d-4c59-b5fb-0c395ed8b1a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdff78af-4e20-43f4-906b-b0cfee6c8d25.pdf",
            "news_date": "2023-02-08 18:30:19",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 7Th February 2023 And Submission Of Audited Financial Results For The Quarter And Nine Months Ended 31St December 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved:<BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as 'Annexure - 1'.<BR> <BR> 2. Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.<BR> <BR> 3. Fixed 17th February 2023 (Friday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 8th March 2023.<BR>",
            "news_id": "7aea45d3-dd3c-4e88-83c8-a2d16bf979fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420930fa-82e8-4e7a-b79f-b668c1097f84.pdf",
            "news_date": "2023-02-07 17:53:42",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 7Th February 2023 And Submission Of Audited Financial Results For The Quarter And Nine Months Ended 31St December 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved: <BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as 'Annexure - 1'.<BR> <BR> 2. Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.<BR> <BR> 3. Fixed 17th February 2023 (Friday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 8th March 2023.<BR> <BR> <BR>",
            "news_id": "b9ba49c0-5366-42e4-9d36-efbedf7b0271",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=986abaff-9cde-458a-8df6-1ae2761db5b7.pdf",
            "news_date": "2023-02-07 17:49:57",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, for the half year ended on 30th September 2022.",
            "news_id": "82d506d8-ed7e-4809-adda-dd0317056185",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7704ee1c-d700-4a49-bf39-4df8e7403cab.pdf",
            "news_date": "2022-11-23 12:16:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For Q2 & FY23",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q2 & FY23",
            "news_id": "e59e809e-bd90-4207-a20f-a08db1d2114b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ceb51b-39ce-4f7f-bc2b-3afcf67a38b1.pdf",
            "news_date": "2022-11-16 14:49:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2FY23",
            "news_id": "2fd59244-b1a2-438a-8ba3-0e5b0e99298f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a06302aa-c8c6-405c-becd-4a7cd4ee6f1f.pdf",
            "news_date": "2022-11-15 13:25:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Press Release",
            "news_body": "Press Release: IOL Chemicals and Pharmaceuticals Reports Q2 FY23 Results",
            "news_id": "0e144dc3-c1c8-4ce9-bf10-044bbf5ecfe1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02e8b81e-d0bc-4ba5-a44f-4e19b8bcc111.pdf",
            "news_date": "2022-11-14 18:59:46",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 14Th November 2022 And Submission Of Audited Financial Results For The Quarter And Half Year Ended 30Th September 2022",
            "news_body": "Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 14th November 2022 has inter alia considered and approved:<BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as Annexure 1.<BR> <BR> 2. Conversion of Unit 9 as multiproduct facility to manufacture other pharma products.<BR> <BR> We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2022 is an Unmodified Report. The meeting of Board of Directors commenced at 4:30 PM and concluded at 6:15 PM.<BR> <BR> The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.",
            "news_id": "c49c6c86-7470-4fab-9eb5-f9c22876d1c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25344dfb-468c-47d5-9de7-f8ab999ba1b8.pdf",
            "news_date": "2022-11-14 18:27:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY 2023 Earnings Conference Call dated 10th August 2022",
            "news_id": "3c32840b-5ea4-4dd3-92d7-40ea9babde8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e45397f-bca8-494a-b0d7-2bd5b8fdba56.pdf",
            "news_date": "2022-08-16 15:05:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For Q1 & FY23",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q1 & FY23",
            "news_id": "402e0e1a-66c9-47d4-87ae-51ed11330012",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85cbb6ea-d366-4a66-ad53-9ce30f5c3308.pdf",
            "news_date": "2022-08-10 18:32:04",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1FY23",
            "news_id": "4cd360c1-118a-4a29-9d9e-6f085805d1fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae609198-496b-463c-b0d3-53d43dff44c2.pdf",
            "news_date": "2022-08-10 15:05:47",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 9Th August 2022 And Submission Of Audited Financial Results For The Quarter Ended 30Th June 2022",
            "news_body": "Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 2022",
            "news_id": "9f086ab9-3ab4-4e13-8294-fd1689a5e842",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd31aa00-844c-4fef-922d-354685bc107b.pdf",
            "news_date": "2022-08-09 20:10:13",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended 30Th June 2022",
            "news_body": "Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 2022",
            "news_id": "d2df9cb1-0013-4a63-b9e0-25d9e00b1a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7933a53b-7d26-4ddc-8ba0-6b858208c250.pdf",
            "news_date": "2022-08-09 20:06:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMDl/OR/P/2021/662 dated 22nd November, 2021, for the half year ended on 31st March, 2022.This is for your information & record.",
            "news_id": "d24cffa2-abdb-4ae4-a9b2-03d5ce679384",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180708f1-9d52-4c34-a94d-82d823ce5203.pdf",
            "news_date": "2022-06-14 13:37:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For 4Q & FY22",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the link to the audio recording of the Analysts/Investors Call on the financial performance of the Company for the Q4 & FY22 held on Wednesday 01st June 2022.LINK: https://www.iolcp.com/uploads/Audio%20Recording%20Earnings%20Call%20Q4%20FY%202022.mp3You are requested to take the same on record.",
            "news_id": "e1930d35-45dd-4def-a9f3-fc724a73a09f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a728a0fc-fdcf-4965-9d2c-677c1bdf0718.pdf",
            "news_date": "2022-06-01 17:21:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4FY22",
            "news_id": "884059d5-ce0d-40c5-8b88-55c135cc20f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=159a72f0-9b3c-4e16-8182-a312ec964f26.pdf",
            "news_date": "2022-05-31 19:21:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2022",
            "news_body": "Submission of Audited Financial Results for the quarter and year ended 31st March 2022",
            "news_id": "6914b2c2-31fa-4403-9236-62c6f58cdb50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed44322b-e008-4abe-888b-e8696b0dbd7a.pdf",
            "news_date": "2022-05-30 20:58:59",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3FY22",
            "news_id": "75c61898-9daf-4551-9173-792a5a3d97ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7253f909-a664-4ead-ac0b-982e41378d83.pdf",
            "news_date": "2022-02-07 17:52:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Nine Months Ended 31St December 2021.",
            "news_body": "Outcome of the Board Meeting dated 4th February 2022 and submission of Audited Financial Results for the quarter and nine months ended 31st December 2021.",
            "news_id": "72886d87-496a-4595-a898-57af9d56fee5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d08da4d-7000-4fbf-8960-eb8edbad03b6.pdf",
            "news_date": "2022-02-04 18:30:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY22",
            "news_id": "40701bca-394a-47b0-819a-28d65122b8c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=accc1c20-f55e-4460-8974-846ff2be0fe5.pdf",
            "news_date": "2021-11-15 18:03:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Half Year Ended 30Th September 2021",
            "news_body": "Pursuant to Regulations 30 & 33 read with para A. 4. h of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations (Listing Regulations), we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th November 2021 has inter alia considered and approved the Audited Financial Results for the Quarter and half year ended 30th September 2021. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith.<BR> <BR> We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2021 is an Unmodified Report. The meeting of Board of Directors commenced at 03:30 PM and concluded at 5:25 PM.<BR> <BR> The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.<BR> <BR> This is for your information & record.",
            "news_id": "743254d8-740f-4037-8717-5a8e2caef73d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7b8972d-94d2-46fe-a795-8e0e426a5e4d.pdf",
            "news_date": "2021-11-12 17:44:29",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the transcript of Earnings Conference Call organized by the Company on 20th August 2021 post declaration of audited financial results for the quarter ended 30th June 2021",
            "news_id": "c811ea4b-8c01-4bad-a849-417204459b4f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7e4ffdf-1ca8-401c-b3cb-bd9ebffa820e.pdf",
            "news_date": "2021-08-31 12:48:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY22",
            "news_id": "93926c97-c256-43ee-954a-2e6b85ad2049",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b69c17c-9cb0-4682-9ee2-16ab76df9a02.pdf",
            "news_date": "2021-08-19 19:00:10",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 13Th August 2021",
            "news_body": "Outcome of the Board Meeting dated 13th August 2021 and submission of Audited Financial Results for the quarter ended 30th June 2021.",
            "news_id": "77c426cf-9632-4609-aa85-8c70edc8364d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6f83dbb-922e-49b0-b3ee-7bdbc34d0cab.pdf",
            "news_date": "2021-08-13 18:55:02",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended 30Th June 2021.",
            "news_body": "Outcome of the Board Meeting dated 13th August 2021 and submission of Audited Financial Results for the quarter ended 30th June 2021.",
            "news_id": "ce4f2aba-3bd3-4fa4-8a53-27a7e5c48183",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9bc076b-cb5d-4dcc-8b8f-e1265e4922ae.pdf",
            "news_date": "2021-08-13 18:50:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Dear Sir,<BR> <BR> In continuation to our letter dated 14th June 2021 regarding intimation of Schedule of analyst/ investors conference call - Q4 & FY2021, please find attached herewith the transcript of Earnings Conference Call organized by the Company on 15th June 2021 post declaration of audited financial results for the quarter and year ended 31st March 2021.<BR> <BR> This is for your information and records.<BR>",
            "news_id": "802f5ea9-7c42-4b5c-96ce-53366600f4bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9190227-e1e8-4e63-8516-8b1f9911be6b.pdf",
            "news_date": "2021-06-19 13:33:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "04745400-19f8-4597-a843-2b5b62d17883",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed91bcfd-ab56-4357-a9b7-e20696df5068.pdf",
            "news_date": "2021-06-14 18:18:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith Disclosure of related party transactions for the year ended 31st March 2021.<BR> <BR>",
            "news_id": "6da23c08-d736-448f-9a20-3f9cbed35634",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66b9356d-15c5-4d51-bdd7-51e6084463c2.pdf",
            "news_date": "2021-06-04 19:43:01",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dt 4Th June 2021 And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2021",
            "news_body": "Outcome of the Board Meeting dated 4th June 2021 and submission of Audited Financial Results for the quarter and year ended 31st March 2021",
            "news_id": "72ad6ef2-8319-4b78-846e-4b3d0b96b47d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45698415-75d3-4aa2-9e72-7bf1abaf020b.pdf",
            "news_date": "2021-06-04 19:37:22",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2021",
            "news_body": "Outcome of the Board Meeting dated 4th June 2021 and submission of Audited Financial Results for the quarter and year ended 31st March 2021",
            "news_id": "f25ecf3c-a3f8-4b1a-9bce-227a21c37f2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2490f8c-003e-4a1b-a606-c34e26c259ab.pdf",
            "news_date": "2021-06-04 19:34:45",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation to our letter dated 15th February 2021 regarding intimation of Schedule of analyst/ investors conference call - Q3 & 9MFY21, please find attached herewith the transcript of Earnings Conference Call organized by the Company on 17th February 2021 post declaration of audited financial results for the quarter and nine months period ended 31st December 2020.",
            "news_id": "eef020a4-cf8c-4ad2-b52b-aa493668cb67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54b079b8-a3f0-41db-b246-3fc43cf3570b.pdf",
            "news_date": "2021-03-01 17:50:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "4ea6c39d-8daa-4c51-950d-f54b679d20f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a3ccef-caaa-428e-9d30-00613105deed.pdf",
            "news_date": "2021-02-16 17:50:32",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}